Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Colorectal Cancer Metastatic × Antineoplastic Agents × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 5 Neoplasms 4 Small Cell Lung Carcinoma 2 Heart Diseases 2 Cardiotoxicity 2 Vascular Diseases 1 Triple Negative Breast Neoplasms 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Cancer Resectable 1 Ovarian Carcinosarcoma 1 Neoplasms, Second Primary 1 Myelodysplastic Syndromes 1 Metabolic Diseases 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Immune-related Adverse Event 1 Heart Failure 1 Esophageal Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Colorectal Cancer Metastatic 1 Carcinoma, Hepatocellular 1 Cancer Therapy-related Cardiovascular Toxicity 1 Breast Neoplasms 1 Advanced Ovarian Cancer 1

Interventions

Bevacizumab 16 Capecitabine 13 Cetuximab 10 Oxaliplatin 7 Irinotecan 7 Fluorouracil 6 Panitumumab 5 trifluridine tipiracil drug combination 3 sintilimab 3 regorafenib 3 Leucovorin 3 Nivolumab 2 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2 Ipilimumab 2 Drug Therapy 2 spartalizumab 1 pembrolizumab 1 irinotecan sucrosofate 1 folfirinox 1 camrelizumab 1 balstilimab 1 anisodamine 1 aflibercept 1 XELOX 1 Vemurafenib 1 Tyrosine Kinase Inhibitors 1 Tomography, X-Ray Computed 1 Spectrum Analysis, Raman 1 Sirtuins 1 SHR-1701 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03923036 2019-04-22

AVOCETTE

University Hospital, Caen

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡